393 Shares in Everus (NYSE:ECG) Bought by SRS Capital Advisors Inc.

SRS Capital Advisors Inc. acquired a new position in shares of Everus (NYSE:ECGFree Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 393 shares of the company’s stock, valued at approximately $26,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Principal Financial Group Inc. acquired a new stake in shares of Everus during the fourth quarter worth $16,241,000. Yousif Capital Management LLC acquired a new stake in shares of Everus during the fourth quarter worth $1,326,000. Principal Securities Inc. acquired a new stake in shares of Everus during the fourth quarter worth $27,000. Cascade Investment Advisors Inc. acquired a new stake in shares of Everus during the fourth quarter worth $1,272,000. Finally, Register Financial Advisors LLC acquired a new stake in shares of Everus during the fourth quarter worth $3,167,000.

Everus Price Performance

Shares of ECG opened at $40.05 on Friday. The company has a 50-day moving average price of $60.68. The company has a quick ratio of 1.50, a current ratio of 1.58 and a debt-to-equity ratio of 0.47. Everus has a one year low of $37.18 and a one year high of $77.93.

Everus (NYSE:ECGGet Free Report) last posted its earnings results on Tuesday, February 11th. The company reported $0.67 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.06). As a group, analysts expect that Everus will post 2.49 EPS for the current year.

Insiders Place Their Bets

In other Everus news, CFO Maximillian J. Marcy purchased 1,300 shares of the firm’s stock in a transaction on Tuesday, February 25th. The stock was purchased at an average cost of $38.99 per share, for a total transaction of $50,687.00. Following the transaction, the chief financial officer now owns 5,508 shares in the company, valued at $214,756.92. The trade was a 30.89 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Rocca Michael Della purchased 1,050 shares of the firm’s stock in a transaction on Tuesday, February 18th. The stock was acquired at an average price of $47.56 per share, with a total value of $49,938.00. Following the completion of the transaction, the director now owns 2,027 shares in the company, valued at approximately $96,404.12. This trade represents a 107.47 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired 3,750 shares of company stock worth $153,853 in the last quarter.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Wolfe Research started coverage on shares of Everus in a report on Tuesday, December 3rd. They set a “peer perform” rating on the stock. Oppenheimer raised their target price on shares of Everus from $70.00 to $80.00 and gave the company an “outperform” rating in a research report on Tuesday, January 7th. Finally, Stifel Nicolaus decreased their target price on shares of Everus from $85.00 to $67.00 and set a “buy” rating for the company in a research report on Thursday, February 13th.

Get Our Latest Research Report on ECG

Everus Company Profile

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Recommended Stories

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECGFree Report).

Institutional Ownership by Quarter for Everus (NYSE:ECG)

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.